Total Payments
$973.27
2024 Payments
$111.23
Companies
11
Transactions
14
Medicare Patients
1,260
Medicare Billing
$114,123
Payment Breakdown by Category
Other$700.00 (71.9%)
Food & Beverage$273.27 (28.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $700.00 | 1 | 71.9% |
| Food and Beverage | $273.27 | 13 | 28.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Richard Wolf Medical Instruments Corp. | $700.00 | 1 | $0 (2023) |
| Smith+Nephew, Inc. | $105.82 | 2 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $30.44 | 2 | $0 (2017) |
| Lexington Medical, Inc. | $28.87 | 1 | $0 (2021) |
| Abbott Laboratories | $18.12 | 1 | $0 (2024) |
| Dexcom, Inc. | $17.91 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $16.08 | 1 | $0 (2017) |
| Innocoll Pharmaceuticals Limited | $15.29 | 1 | $0 (2022) |
| Lifenet Health | $14.65 | 2 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.05 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $111.23 | 2 | Smith+Nephew, Inc. ($93.11) |
| 2023 | $745.27 | 5 | Richard Wolf Medical Instruments Corp. ($700.00) |
| 2022 | $15.29 | 1 | Innocoll Pharmaceuticals Limited ($15.29) |
| 2021 | $41.91 | 2 | Lexington Medical, Inc. ($28.87) |
| 2018 | $13.05 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($13.05) |
| 2017 | $46.52 | 3 | Takeda Pharmaceuticals America, Inc. ($30.44) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2024 | Abbott Laboratories | ENSITE (Device) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Electrophysiology | ||||||
| 03/18/2024 | Smith+Nephew, Inc. | GRAFIX (Medical Supply), OASIS, STRAVIX | Food and Beverage | In-kind items and services | $93.11 | General |
| Category: Other Advanced Wound Management | ||||||
| 10/23/2023 | Smith+Nephew, Inc. | Iodosorb Ointment 40g USA (Device), REGRANEX, COLLAGENASE SANTYL | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Infection Management | ||||||
| 09/26/2023 | Lifenet Health | TheraGenesis Wound Matrix (Device) | Food and Beverage | Cash or cash equivalent | $7.88 | General |
| Category: Wound | ||||||
| 09/20/2023 | Lifenet Health | TheraGenesis Wound Matrix (Device) | Food and Beverage | Cash or cash equivalent | $6.77 | General |
| Category: Wound | ||||||
| 08/24/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Endocrinology | ||||||
| 06/12/2023 | Richard Wolf Medical Instruments Corp. | — | Honoraria | Cash or cash equivalent | $700.00 | General |
| 10/06/2022 | Innocoll Pharmaceuticals Limited | XARACOLL (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Prescription Drug | ||||||
| 10/14/2021 | Medtronic, Inc. | VenaSeal (Device) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: EndoVenous Therapies | ||||||
| 09/14/2021 | Lexington Medical, Inc. | Aeon Endostapler (Device) | Food and Beverage | Cash or cash equivalent | $28.87 | General |
| Category: Surgical stapling device | ||||||
| 05/24/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Central Nervous System (CNS) | ||||||
| 11/13/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: Central Nervous System (CNS) | ||||||
| 03/23/2017 | Takeda Pharmaceuticals America, Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Lower GI | ||||||
| 01/17/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 415 | 481 | $181,712 | $39,090 |
| 2022 | 8 | 299 | 343 | $127,755 | $26,335 |
| 2021 | 9 | 264 | 363 | $101,522 | $25,637 |
| 2020 | 8 | 282 | 345 | $103,544 | $23,061 |
Total Patients
1,260
Total Services
1,532
Medicare Billing
$114,123
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 48 | 48 | $44,695 | $7,057 | 15.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 101 | $18,921 | $6,657 | 35.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 74 | 74 | $16,913 | $5,315 | 31.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 52 | $10,809 | $4,763 | 44.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 69 | 69 | $56,081 | $4,361 | 7.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 44 | $11,703 | $3,727 | 31.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $7,904 | $2,808 | 35.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 29 | $4,208 | $1,786 | 42.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $8,134 | $1,459 | 17.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 30 | $2,343 | $1,157 | 49.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 72 | 84 | $15,695 | $5,551 | 35.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 81 | 81 | $20,637 | $5,281 | 25.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 28 | 28 | $27,011 | $4,199 | 15.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 44 | $12,014 | $3,501 | 29.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 40 | 40 | $32,473 | $2,333 | 7.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 12 | 12 | $10,827 | $2,143 | 19.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 37 | $5,564 | $2,006 | 36.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 17 | $3,534 | $1,321 | 37.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 41 | 66 | $18,678 | $6,344 | 34.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 51 | 51 | $14,433 | $3,986 | 27.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 34 | 49 | $9,408 | $3,420 | 36.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 32 | 32 | $11,840 | $3,353 | 28.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 37 | 88 | $11,352 | $2,641 | 23.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 22 | 22 | $9,636 | $2,384 | 24.7% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 22 | 22 | $17,798 | $1,646 | 9.2% |
About Dr. Bobby Smith, DO
Dr. Bobby Smith, DO is a Surgery healthcare provider based in Pampa, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629012000.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bobby Smith, DO has received a total of $973.27 in payments from pharmaceutical and medical device companies, with $111.23 received in 2024. These payments were reported across 14 transactions from 11 companies. The most common payment nature is "Honoraria" ($700.00).
As a Medicare-enrolled provider, Smith has provided services to 1,260 Medicare beneficiaries, totaling 1,532 services with total Medicare billing of $114,123. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgery
- Location Pampa, TX
- Active Since 06/15/2006
- Last Updated 11/25/2025
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1629012000
Products in Payments
- GRAFIX (Medical Supply) $93.11
- Aeon Endostapler (Device) $28.87
- Trintellix (Drug) $26.03
- ENSITE (Device) $18.12
- Dexcom G6 Transmitter (Medical Supply) $17.91
- Amitiza (Drug) $17.46
- FARXIGA (Drug) $16.08
- XARACOLL (Drug) $15.29
- TheraGenesis Wound Matrix (Device) $14.65
- VenaSeal (Device) $13.04
- Iodosorb Ointment 40g USA (Device) $12.71
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.